Chapter/Section Purchase

Leave This Empty:

Latent TB Infection Testing Market, Global Outlook and Forecast 2022-2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Latent TB Infection Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Latent TB Infection Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Latent TB Infection Testing Overall Market Size
2.1 Global Latent TB Infection Testing Market Size: 2021 VS 2028
2.2 Global Latent TB Infection Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Latent TB Infection Testing Players in Global Market
3.2 Top Global Latent TB Infection Testing Companies Ranked by Revenue
3.3 Global Latent TB Infection Testing Revenue by Companies
3.4 Top 3 and Top 5 Latent TB Infection Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Latent TB Infection Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Latent TB Infection Testing Players in Global Market
3.6.1 List of Global Tier 1 Latent TB Infection Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Latent TB Infection Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Latent TB Infection Testing Market Size Markets, 2021 & 2028
4.1.2 Mantoux Test / Tuberculin Skin Test (TST)
4.1.3 Interferon-Gamma Release Assay (IGRA)
4.2 By Type - Global Latent TB Infection Testing Revenue & Forecasts
4.2.1 By Type - Global Latent TB Infection Testing Revenue, 2017-2022
4.2.2 By Type - Global Latent TB Infection Testing Revenue, 2023-2028
4.2.3 By Type - Global Latent TB Infection Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Latent TB Infection Testing Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Public and Student Health
5.1.4 Physician Offices and Clinics
5.1.5 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
5.2 By Application - Global Latent TB Infection Testing Revenue & Forecasts
5.2.1 By Application - Global Latent TB Infection Testing Revenue, 2017-2022
5.2.2 By Application - Global Latent TB Infection Testing Revenue, 2023-2028
5.2.3 By Application - Global Latent TB Infection Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Latent TB Infection Testing Market Size, 2021 & 2028
6.2 By Region - Global Latent TB Infection Testing Revenue & Forecasts
6.2.1 By Region - Global Latent TB Infection Testing Revenue, 2017-2022
6.2.2 By Region - Global Latent TB Infection Testing Revenue, 2023-2028
6.2.3 By Region - Global Latent TB Infection Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Latent TB Infection Testing Revenue, 2017-2028
6.3.2 US Latent TB Infection Testing Market Size, 2017-2028
6.3.3 Canada Latent TB Infection Testing Market Size, 2017-2028
6.3.4 Mexico Latent TB Infection Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Latent TB Infection Testing Revenue, 2017-2028
6.4.2 Germany Latent TB Infection Testing Market Size, 2017-2028
6.4.3 France Latent TB Infection Testing Market Size, 2017-2028
6.4.4 U.K. Latent TB Infection Testing Market Size, 2017-2028
6.4.5 Italy Latent TB Infection Testing Market Size, 2017-2028
6.4.6 Russia Latent TB Infection Testing Market Size, 2017-2028
6.4.7 Nordic Countries Latent TB Infection Testing Market Size, 2017-2028
6.4.8 Benelux Latent TB Infection Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Latent TB Infection Testing Revenue, 2017-2028
6.5.2 China Latent TB Infection Testing Market Size, 2017-2028
6.5.3 Japan Latent TB Infection Testing Market Size, 2017-2028
6.5.4 South Korea Latent TB Infection Testing Market Size, 2017-2028
6.5.5 Southeast Asia Latent TB Infection Testing Market Size, 2017-2028
6.5.6 India Latent TB Infection Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Latent TB Infection Testing Revenue, 2017-2028
6.6.2 Brazil Latent TB Infection Testing Market Size, 2017-2028
6.6.3 Argentina Latent TB Infection Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Latent TB Infection Testing Revenue, 2017-2028
6.7.2 Turkey Latent TB Infection Testing Market Size, 2017-2028
6.7.3 Israel Latent TB Infection Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Latent TB Infection Testing Market Size, 2017-2028
6.7.5 UAE Latent TB Infection Testing Market Size, 2017-2028
7 Players Profiles
7.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
7.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Corporate Summary
7.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
7.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Major Product Offerings
7.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Key News
7.2 Pharmstandard (Generium Pharmaceutical)
7.2.1 Pharmstandard (Generium Pharmaceutical) Corporate Summary
7.2.2 Pharmstandard (Generium Pharmaceutical) Business Overview
7.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Major Product Offerings
7.2.4 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.2.5 Pharmstandard (Generium Pharmaceutical) Key News
7.3 Sanofi S.A./Sanofi Pasteur Ltd.
7.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Corporate Summary
7.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
7.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Major Product Offerings
7.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Key News
7.4 Statens Serum Institut (SSI)
7.4.1 Statens Serum Institut (SSI) Corporate Summary
7.4.2 Statens Serum Institut (SSI) Business Overview
7.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Major Product Offerings
7.4.4 Statens Serum Institut (SSI) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.4.5 Statens Serum Institut (SSI) Key News
7.5 Autoimmun Diagnostika (AID) GmbH
7.5.1 Autoimmun Diagnostika (AID) GmbH Corporate Summary
7.5.2 Autoimmun Diagnostika (AID) GmbH Business Overview
7.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Major Product Offerings
7.5.4 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.5.5 Autoimmun Diagnostika (AID) GmbH Key News
7.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
7.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Corporate Summary
7.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
7.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Major Product Offerings
7.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Key News
7.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
7.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Corporate Summary
7.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
7.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Major Product Offerings
7.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Key News
7.8 Immunoshop India Pvt. Ltd.
7.8.1 Immunoshop India Pvt. Ltd. Corporate Summary
7.8.2 Immunoshop India Pvt. Ltd. Business Overview
7.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Major Product Offerings
7.8.4 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.8.5 Immunoshop India Pvt. Ltd. Key News
7.9 Qiagen N.V.
7.9.1 Qiagen N.V. Corporate Summary
7.9.2 Qiagen N.V. Business Overview
7.9.3 Qiagen N.V. Latent TB Infection Testing Major Product Offerings
7.9.4 Qiagen N.V. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.9.5 Qiagen N.V. Key News
7.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
7.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Corporate Summary
7.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
7.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Major Product Offerings
7.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Key News
7.11 SD Biosensor, Inc.
7.11.1 SD Biosensor, Inc. Corporate Summary
7.11.2 SD Biosensor, Inc. Business Overview
7.11.3 SD Biosensor, Inc. Latent TB Infection Testing Major Product Offerings
7.11.4 SD Biosensor, Inc. Latent TB Infection Testing Revenue in Global Market (2017-2022)
7.11.5 SD Biosensor, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer